Indian Journal of Medical Research

CLINICAL IMAGES
Year
: 2017  |  Volume : 146  |  Issue : 1  |  Page : 141-

Complete response of metastatic gastric cancer to chemoimmunotherapy


Kenji Ina, Ryuichi Furuta 
 Department of Medical Oncology, Nagoya Memorial Hospital, Nagoya, Japan

Correspondence Address:
Kenji Ina
Department of Medical Oncology, Nagoya Memorial Hospital, Nagoya
Japan




How to cite this article:
Ina K, Furuta R. Complete response of metastatic gastric cancer to chemoimmunotherapy.Indian J Med Res 2017;146:141-141


How to cite this URL:
Ina K, Furuta R. Complete response of metastatic gastric cancer to chemoimmunotherapy. Indian J Med Res [serial online] 2017 [cited 2020 Jul 4 ];146:141-141
Available from: http://www.ijmr.org.in/text.asp?2017/146/1/141/219008


Full Text



A 64 yr old man with a complaint of abdominal pain, presented to the department of Medical Oncology, Nagoya Memorial Hospital, Nagoya, Japan, in August 2010. Computed tomography demonstrated multiple liver tumours [Figure 1]. Advanced gastric cancer type 2 was diagnosed using gastrointestinal videoendoscopy [Figure 2]. Triple therapy with S-1, paclitaxel and cisplatin in combination with lentinan, a representative mushroom β-glucan, was initiated. Re-evaluation after six cycles showed complete disappearance of the primary gastric lesion in April 2011 and only S-1 was continued in combination with lentinan. Complete disappearance of liver metastases and primary gastric lesions was observed in April 2013 [Figure 3] and [Figure 4]. Chemoimmunotherapy was stopped due to grade 3 skin-related adverse effects. During the follow up period of 33 months no evidence of recurrence was seen.{Figure 1}{Figure 2}{Figure 3}{Figure 4}